Brief: ISR Starts Two New Programs Against TBC And Cancer
Jan 22 (Reuters) - ISR IMMUNE SYSTEM REGULATION HOLDING AB
(PUBL) ISR.ST :
* ISR IMMUNE SYSTEM REGULATION HOLDING AB STARTS TWO NEW
PROGRAMS
AGAINST TBC AND CANCER
* PLANS TO INITIATE A PHASE I SAFETY STUDY IN HUMANS DURING
FALL
OF 2018
Source text for Eikon: ID:nWkr4nQNfC
Further company coverage: ISR.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on ISR Immune System Regulation Holding AB (publ)
See all newsBrief: ISR Holding Shares To Be Delisted From Nasdaq First North Growth Market
Brief: Nasdaq Stockholm Hands Over Investigation Of ISR Holding To Disciplinary Committee
Brief: ISR Immune System Regulation Holding Receives Notice Of Objection From Nasdaq
Brief: ISR FY 2022 Oper Loss Widens To SEK 205.1 Mln
Brief: ISR Signs Development Agreements With Catalent